Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 55 | Issue 2 | 2021 | pp. 436–444Open access
Determination of Haematological Effects of Extracts of Reseda sphenocleoides Leaves in Albino Rats Infected with Entamoeba histolytica
- 1*,
- 1,
- 2,
- 1,
- 1
- 1 Department of Zoology, Dr. Rafiq Zakaria College for Women, Aurangabad, Maharashtra, INDIA.
- 2 Department of Chemistry, Maulana Azad College of Art, Science and Commerce, Aurangabad, Maharashtra, INDIA.
- 3 Department of Biochemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Mansour Abdulnabi Hadi Mehdi
Department of Zoology, Dr. Rafiq Zakaria College for Women, Aurangabad, Maharashtra, INDIA.
Email: mansourabdulnabi@gmail.com
Copyright: © 2021 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2021
- Received:
- Apr 17, 2020
- Accepted:
- Jan 15, 2021
- DOI:
- 10.5530/ijper.55.2.81
How to cite
Mehdi, M. A. H., Pradhan, V., Farooqui, M., Alarabi, F. Y. S., & Omar, G. M. N. (2021). Determination of Haematological Effects of Extracts of Reseda sphenocleoides Leaves in Albino Rats Infected with Entamoeba histolytica. Indian Journal of Pharmaceutical Education and Research, 55(2), 436–444. https://doi.org/10.5530/ijper.55.2.81
Abstract
Objectives: This research was designed to examine improvements in some heamatological parameters of Entamoeba histolytica-infected rats treated with extracts of Reseda sphenocleoides leaves. Methods: Twenty rats weighing between 200-220 g were divided into 4 groups (Each per group containing 5 rats). Fifteen rats were infected by oral administration (17×103 cell/ml) of E. histolytica obtained from the stool. Infected rats were classified in differentiated three groups A, B, C. In addition, the negative control group E. The groups (A and B) were administered with the ethanolic and aqueous extracts at the dose of 500 mg/kg body weight/day, the group C was administered with metronidazole, in a dose 500 mg/kg body weight (Positive control group). The negative control group E was uninfected and untreated. The hematological parameters in the different groups were monitored throughout the period of study which was 10 days on three stages. Results: The results show a significant increase at P≤0.05 in Red Blood Cell Count (RBC), Haemoglobin (Hb), Hematocrit (HCT), Mean Cell Volume (MCV), Red Cell Distribution Width (RDW), Procalcitonin Test (PCT) and Lymphocyte (LY) in groups which treated with R. sphenocleoides extracts compare with metronidazole drug and the negative control group during treatment stages. While the results show a decrease of significant at P≤0.05 in Platelet (PLT), Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), Total White Blood Cell (WBC), Monocyte (MO) and Granulocytes (GR) in groups which treated with R. sphenocleoides extracts in comparison with the control groups of rats. The results also indicate no changes of significance at P>0.05 in Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC) during treatment stages. Conclusion: The findings of this study, the efficiency of R. sphenocleoides extracts in improving blood standards in rats infected with E. histolytica.
Keywords
Subject
Article metadata
| Title | Determination of Haematological Effects of Extracts of Reseda sphenocleoides Leaves in Albino Rats Infected with Entamoeba histolytica |
|---|---|
| Authors | Mansour Abdulnabi Hadi Mehdi; Vidya Pradhan; Mazahar Farooqui; Fadel Yousif Salah Alarabi; Gozif Mohammed Nasr Omar |
| Affiliations | Department of Zoology, Dr. Rafiq Zakaria College for Women, Aurangabad, Maharashtra, INDIA.; Department of Chemistry, Maulana Azad College of Art, Science and Commerce, Aurangabad, Maharashtra, INDIA.; Department of Biochemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, INDIA. |
| Corresponding author | mansourabdulnabi@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 55, Issue 2 (2021) |
Also in this issue
- Artificial Intelligence in Pharmacypp. 304–318
- Possible Insights into the Use of Silver Nanoparticles in Targeting SARS-CoV-2 (COVID-19)pp. 319–329
- An Overview of Dual Targeting Nanostructured Lipid Carriers for the Treatment of Ovarian Cancerpp. 330–335
- Overview of FBO Licensing in the India and New Dietary Ingredient Notification in the USpp. 336–345
- Targeted Drug Delivery System: Advantages, Carriers and Strategiespp. 346–353